Skip to main content

Self-Management Strategies for Peripheral Neuropathy: A Breast Cancer Awareness Month Interview With Connie Visovsky, PhD, RN, ACNP, FAAN

In this interview for Breast Cancer Awareness Month, Dr. Connie Visovsky, Professor and Endowed Chair in Nursing Science at the University of South Florida, shares her research regarding exercise as a self-management strategy for chemotherapy-induced peripheral neuropathy (CIPN) experienced by patients during breast cancer treatment. Additionally, she gives an update on her presentation from last year's ODACon Breast Cancer Symposium regarding new directions in research for CDK4/6 inhibitors.  

Continue reading

Self-Management Strategies for Peripheral Neuropathy: A Breast Cancer Awareness Month Interview With Connie Visovsky, PhD, RN, ACNP, FAAN

Oncology Data Advisor® · Self-Management Strategies for Peripheral Neuropathy With Connie Visovsky, PhD, RN, ACNP, FAAN In this interview for Breast Cancer Awareness Month, Dr. Connie Visovsky, Professor and Endowed Chair in Nursing Science at the University of South Florida, shares her research regarding exercise as a self-management strategy for chemotherapy-induced peripheral neuropathy (CIPN) experienced by patients during breast cancer treatment. Additionally, she gives an update...

Continue reading

Shortened Oxaliplatin-Based Chemo Course Reduces Neuropathy Risk

Oxaliplatin-based chemotherapy, while effective, can cause peripheral sensory neuropathy (PSN)—an incurable, debilitating condition in which peripheral nerve damage occurs and causes muscle weakness, pain, and pins and needles sensation, among other symptoms—in patients with stage III colon cancer. However, researchers recently discovered that a shortened three-month course of adjuvant oxaliplatin-based chemotherapy reduces the risk of PSN in patients with stage III colon cancer. For this study,...

Continue reading